NCR1 and glioblastoma: The NK-mediated killing of glioblastoma cells (GBM) has been identified by the low levels of HLA class I both classical (HLA-A, -B, -C) and non-classical (HLA-E) molecules and by the expression of DNAM-1 and NKp46 activating NK receptors.